Related references
Note: Only part of the references are listed.High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failure
Muhammad Hammadah et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus
Krisztina Gaal et al.
LIPIDS IN HEALTH AND DISEASE (2016)
Paraoxonase 1 Activity Is Modulated by the rs662 Polymorphism and IgG Anti-High-Density Lipoprotein Antibodies in Patients With Rheumatoid Arthritis Potential Implications for Cardiovascular Disease
Javier Rodriguez-Carrio et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Impaired Antiatherogenic Functions of High-density Lipoprotein in Patients with Ankylosing Spondylitis
Christina Gkolfinopoulou et al.
JOURNAL OF RHEUMATOLOGY (2015)
Psoriasis decreases the anti-oxidation and anti-inflammation properties of high-density lipoprotein
Lei He et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
Hassan El-Banna et al.
BMC MUSCULOSKELETAL DISORDERS (2014)
From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies
Jeremy Hugh et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Neil J. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
Anand Rohatgi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effect of HDL-Raising Drugs on Cardiovascular Outcomes: A Systematic Review and Meta-Regression
Navjot Kaur et al.
PLOS ONE (2014)
Relationship Between Metabolic Syndrome and Carotid Intima-Media Thickness: Cross-Sectional Comparison Between Psoriasis and Psoriatic Arthritis
Yih Chang Lin et al.
ARTHRITIS CARE & RESEARCH (2014)
Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity
Lihi Eder et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Association of Paraoxonase 1 Gene Polymorphism and Enzyme Activity With Carotid Plaque in Rheumatoid Arthritis
Christina Charles-Schoeman et al.
ARTHRITIS AND RHEUMATISM (2013)
Incidence of Cardiovascular Disease in Individuals with Psoriasis: A Systematic Review and Meta-Analysis
Eleanor J. Samarasekera et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors
Iben Marie Miller et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis
Shereem Mohamed Olama et al.
RHEUMATOLOGY INTERNATIONAL (2013)
Clinical and Genetic Association of Serum Paraoxonase and Arylesterase Activities With Cardiovascular Risk
W. H. Wilson Tang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Diminished Antioxidant Activity of High-Density Lipoprotein-Associated Proteins in Systolic Heart Failure
W. H. Wilson Tang et al.
CIRCULATION-HEART FAILURE (2011)
The immune system in atherosclerosis
Goran K. Hansson et al.
NATURE IMMUNOLOGY (2011)
Carotid intima-media thickness and paraoxonase activity in patients with ankylosing spondylitis
Hasan Cece et al.
CLINICAL AND INVESTIGATIVE MEDICINE (2011)
EVALUATION OF SERUM PARAOXONASE AND ARYLESTERASE ACTIVITIES IN ANKYLOSING SPONDYLITIS PATIENTS
Fazile Hatipoglu Erdem et al.
CLINICS (2010)
Dysfunctional Proinflammatory High-Density Lipoproteins Confer Increased Risk of Atherosclerosis in Women With Systemic Lupus Erythematosus
Maureen McMahon et al.
ARTHRITIS AND RHEUMATISM (2009)
Serum lipid profile paraoxonase and arylesterase activities in psoriasis
Aysun Toker et al.
CELL BIOCHEMISTRY AND FUNCTION (2009)
The roles of PON1 and PON2 in cardiovascular disease and innate immunity
Diana M. Shih et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk
Tamali Bhattacharyya et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Mannheim carotid intima-media thickness consensus (2004-2006) - An update on behalf of the advisory board of the 3rd and 4th watching the risk Symposium 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006
P. -J. Touboul et al.
CEREBROVASCULAR DISEASES (2007)
Classification criteria for psoriatic arthritis - Development of new criteria from a large international study
William Taylor et al.
ARTHRITIS AND RHEUMATISM (2006)
Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis
Maureen McMahon et al.
ARTHRITIS AND RHEUMATISM (2006)
Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus
Laura M. Tripi et al.
ARTHRITIS AND RHEUMATISM (2006)
Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis
G Baskol et al.
CLINICAL BIOCHEMISTRY (2005)
Pathophysiology of coronary artery disease
P Libby et al.
CIRCULATION (2005)
Myeloperoxidase and cardiovascular disease
SJ Nicholls et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
D Aletaha et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis
SP McKenna et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease
LM Zheng et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Serum paraoxonase activity decreases in rheumatoid arthritis
N Tanimoto et al.
LIFE SCIENCES (2003)
Association between myeloperoxidase levels and risk of coronary artery disease
ZL Zhang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Paraoxonase and atherosclerosis
PN Durrington et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Share Paper
